IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 201 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,711,949 | +136.1% | 2,462,300 | +160.9% | 0.05% | +145.5% |
| Q2 2023 | $10,042,032 | -27.6% | 943,800 | -31.4% | 0.02% | -46.3% |
| Q1 2020 | $13,874,000 | -24.2% | 1,375,000 | 0.0% | 0.04% | -8.9% |
| Q4 2019 | $18,301,000 | +215.8% | 1,375,000 | +103.7% | 0.04% | +221.4% |
| Q3 2019 | $5,795,000 | -21.5% | 675,000 | 0.0% | 0.01% | -22.2% |
| Q2 2019 | $7,385,000 | -70.9% | 675,000 | -64.0% | 0.02% | -71.4% |
| Q1 2019 | $25,369,000 | +30.6% | 1,875,000 | 0.0% | 0.06% | +16.7% |
| Q4 2018 | $19,425,000 | -55.7% | 1,875,000 | -21.1% | 0.05% | -44.9% |
| Q3 2018 | $43,843,000 | +22.3% | 2,375,000 | +26.7% | 0.10% | +19.5% |
| Q2 2018 | $35,850,000 | +23.9% | 1,875,000 | 0.0% | 0.08% | +22.4% |
| Q1 2018 | $28,931,000 | +2.5% | 1,875,000 | -0.5% | 0.07% | +4.7% |
| Q4 2017 | $28,238,000 | -38.3% | 1,883,793 | -35.0% | 0.06% | -42.3% |
| Q3 2017 | $45,733,000 | -29.3% | 2,900,000 | -15.3% | 0.11% | -29.7% |
| Q2 2017 | $64,664,000 | -36.3% | 3,425,000 | -42.4% | 0.16% | -38.3% |
| Q1 2017 | $101,507,000 | +11.6% | 5,950,000 | 0.0% | 0.26% | +2.8% |
| Q4 2016 | $90,976,000 | +5.6% | 5,950,000 | +9.7% | 0.25% | +5.1% |
| Q3 2016 | $86,143,000 | +246.7% | 5,424,600 | +185.5% | 0.24% | +248.5% |
| Q2 2016 | $24,843,000 | +152.3% | 1,900,000 | +111.1% | 0.07% | +151.9% |
| Q1 2016 | $9,846,000 | +40.3% | 900,000 | +66.2% | 0.03% | +58.8% |
| Q3 2014 | $7,016,000 | -60.8% | 541,576 | -53.6% | 0.02% | -63.0% |
| Q2 2014 | $17,899,000 | +232.0% | 1,167,581 | +166.8% | 0.05% | +206.7% |
| Q1 2014 | $5,391,000 | -44.8% | 437,549 | -48.0% | 0.02% | -42.3% |
| Q4 2013 | $9,761,000 | -51.2% | 840,711 | -50.3% | 0.03% | -55.2% |
| Q3 2013 | $20,020,000 | +19.2% | 1,690,911 | 0.0% | 0.06% | +11.5% |
| Q2 2013 | $16,791,000 | -36.3% | 1,690,911 | +17.4% | 0.05% | -40.2% |
| Q1 2013 | $26,347,000 | – | 1,440,912 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |